When drug manufacturers raise the list price for prescription drugs, do patients’ out-of-pocket costs rise too?
Researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
4 May 2021Little to no increase in association between adolescents’ mental health problems and digital tech
4 May 2021When drug manufacturers raise the list price for prescription drugs, do patients’ out-of-pocket costs rise too?
When drug manufacturers raise the list price for brand-name prescription drugs, do patients’ out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham’s Division of Pharmacoepidemiology and Pharmacoeconomics finds that more than half of patients may experience increases in out-of-pocket spending when drug prices increase.
